rs10500796

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000354817.8(FAR1):​c.-8+8480A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 152,146 control chromosomes in the GnomAD database, including 2,936 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.19 ( 2936 hom., cov: 32)

Consequence

FAR1
ENST00000354817.8 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.854

Publications

5 publications found
Variant links:
Genes affected
FAR1 (HGNC:26222): (fatty acyl-CoA reductase 1) The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
FAR1 Gene-Disease associations (from GenCC):
  • fatty acyl-CoA reductase 1 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen
  • spastic paraparesis-cataracts-speech delay syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • fatty acyl-CoA reductase 1 upregulation
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • hereditary spastic paraplegia 9A
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.202 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000354817.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAR1
NM_032228.6
MANE Select
c.-8+8480A>G
intron
N/ANP_115604.1
FAR1
NM_001441242.1
c.-8+8480A>G
intron
N/ANP_001428171.1
FAR1
NM_001441243.1
c.-8+8480A>G
intron
N/ANP_001428172.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FAR1
ENST00000354817.8
TSL:1 MANE Select
c.-8+8480A>G
intron
N/AENSP00000346874.3
FAR1
ENST00000714156.1
c.-8+6086A>G
intron
N/AENSP00000519445.1
FAR1
ENST00000714157.1
c.-8+8480A>G
intron
N/AENSP00000519446.1

Frequencies

GnomAD3 genomes
AF:
0.191
AC:
29006
AN:
152026
Hom.:
2923
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.166
Gnomad AMI
AF:
0.192
Gnomad AMR
AF:
0.200
Gnomad ASJ
AF:
0.119
Gnomad EAS
AF:
0.180
Gnomad SAS
AF:
0.132
Gnomad FIN
AF:
0.246
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.205
Gnomad OTH
AF:
0.166
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.191
AC:
29059
AN:
152146
Hom.:
2936
Cov.:
32
AF XY:
0.191
AC XY:
14192
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.167
AC:
6929
AN:
41516
American (AMR)
AF:
0.200
AC:
3059
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.119
AC:
413
AN:
3472
East Asian (EAS)
AF:
0.180
AC:
930
AN:
5174
South Asian (SAS)
AF:
0.133
AC:
639
AN:
4822
European-Finnish (FIN)
AF:
0.246
AC:
2599
AN:
10580
Middle Eastern (MID)
AF:
0.170
AC:
50
AN:
294
European-Non Finnish (NFE)
AF:
0.205
AC:
13918
AN:
67976
Other (OTH)
AF:
0.164
AC:
347
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1186
2373
3559
4746
5932
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.197
Hom.:
12849
Bravo
AF:
0.187
Asia WGS
AF:
0.152
AC:
531
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.77
DANN
Benign
0.36
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10500796; hg19: chr11-13698833; API